Chronic kidney disease in the elderly: Assessment and management

Australian Family Physician

Volumn 41, Issue 12, 2012, Pages 940-944

  Phoon, Richard K S ^a  

^a Western Renal Service   (Australia)

Author keywords

Elderly; Kidney disease; Renal insufficiency

Indexed keywords

CREATININE;

AGED; ARTICLE; BLOOD; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CLASSIFICATION; GLOMERULUS FILTRATION RATE; HUMAN; PROTEINURIA;

AGED; BLOOD PRESSURE; CREATININE; GLOMERULAR FILTRATION RATE; HUMANS; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84871167900     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Australian Institute of Health and Welfare. An overview of chronic kidney disease in Australia, 2009. Canberra: AIHW, 2009.
2. Australian Institute of Health and Welfare. Chronic kidney disease hospitalisations in Australia 2000-01 to 2007-08. Canberra: AIHW, 2010.
3. Johnson DW. Evidence-based guide to slowing the progression of early renal insufficiency. Intern Med J 2004;34:50-7.
4. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12.
5. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003;14(7 Suppl 2):S131-8.
6. White SL, Polkinghorne KR, Atkins RC, Chadban SJ. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. Am J Kidney Dis 2010;55:660-70.
7. Baggio B, Budakovic A, Perissinotto E, et al. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA). Nephrol Dial Transplant 2005;20:114-23.
8. Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997;51:1196-204.
9. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278-85.
10. Bowling CB, Inker LA, Gutierrez OM, et al. Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications. Clin J Am Soc Nephrol 2011;6:2822-8.
11. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney diseaseand the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
12. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal followup and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-63.
13. Johnson DW, Jones GR, Mathew TH, et al. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations. Med J Aust 2012;197:224-5.
14. Mathew TH, Corso O, Ludlow M, et al. Screening for chronic kidney disease in Australia: a pilot study in the community and workplace. Kidney Int 2010;77(S116):S9-16.
15. Australian Institute of Health and Welfare. Chronic kidney disease in Aboriginal and Torres Strait Islander people. Canberra: AIHW, 2011.
16. Johnson DW, Jones GR, Mathew TH, et al. Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement. Med J Aust 2012;197:224-5.
17. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-81.
18. Casas JP, Chua W, Loukogeorgakis S, et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005;366:2026-33.
19. Giatras I, Lau J, Levey AS. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med 1997;127:337-45.
20. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.
21. Hou FF, Zhang X, Zhang GH, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 2006;354:131-40.
22. Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547-59.
23. Bakris GL, Sarafidis PA, Weir MR, et al. Renal outcomes with different fixeddose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 2010;375:1173-81.
24. Bakris GL, Toto RD, McCullough PA, Rocha R, Purkayastha D, Davis P. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int 2008;73:1303-9.
25. Upadhyay A, Earley A, Haynes SM, Uhlig K. Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med 2011;154:541-8.
26. Diabetes Australia. Diabetes management in general practice. 17th edn, 2011.
27. Gotloib L, Silverberg D, Fudin R, Shostak A. Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron. J Nephrol 2006;19:161-7.
28. Kandula P, Dobre M, Schold JD, Schreiber MJ Jr, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011;6:50-62.
29. Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant 2011;26:1608-14.
30. Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009;361:1539-47.
31. Bowling CB, O'Hare AM. Managing older adults with CKD: individualized versus disease-based approaches. Am J Kidney Dis 2012;59:293-302.
32. Weiss JW, Johnson ES, Petrik A, Smith DH, Yang X, Thorp ML. Systolic blood pressure and mortality among older community-dwelling adults with CKD. Am J Kidney Dis 2010;56:1062-71.
33. Kidney Health Australia. Chronic disease management in general practice. 2nd edn, 2012. Available at www.kidney.org.au/LinkClick.aspx?fileticket=sMKP3HBuquM%3d&tabid=635 &mid=1584.
34. Faull R. Lee L. Prescribing in renal disease. Aust Prescr 2007;30:17-20.